GlassScriptPhysician profile
Steven C Pearse
NPI 1144296856
$1,731.52
in general payments reported to CMS, 2019-2025
13 companies · $68.87 in 2025
The $68.87 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $335 · 2021: $143 · 2022: $78.62 · 2023: $423 · 2024: $237 · 2025: $68.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $480.68 | 2019-2025 | Puraply, Puraply Wound Matrix, Puraply Franchise |
| Smith+Nephew, INC. | $402.67 | 2019-2025 | Collagenase Santyl |
| Misonix INC | $176.16 | 2019-2020 | |
| Amgen INC. | $136.97 | 2024 | Krystexxa |
| Tactile Systems Technology INC | $136.77 | 2020-2022 | |
| Kci USA, INC. | $101.34 | 2019 | |
| Bioventus LLC | $68.25 | 2023 | Sonicone Clinic |
| Painteq LLC | $56.19 | 2023 | Painteq |
| Aroa Biosurgery Incorporated | $52.13 | 2019 | |
| Integra Lifesciences Corporation | $47.74 | 2019-2021 | |
| Davol INC. | $36.58 | 2023 | Channel Drain |
| Hydrofera LLC | $21.03 | 2021 | |
| Merck Sharp & Dohme LLC | $15.01 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Pearse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.